Joe G.N. “Skip” Garcia, MD

FOUNDER & CHIEF EXECUTIVE OFFICER

Joe G. N. "Skip" Garcia, MD, is an internationally-noted pulmonary physician-scientist, an endowed professor of medicine at the University of Arizona College of Medicine – Tucson, and an elected member of the National Academy of Medicine. A noted academic health system administrator, scholar and educator, Dr. Garcia is a leading authority on the genetic basis of lung disease and the prevention and treatment of inflammatory lung injury. Dr. Garcia is internationally recognized for development of novel biomarkers and therapies for critically ill patients with acute inflammatory lung disease and for addressing health disparities in vulnerable populations. He has over 575 peer-reviewed publications, an expansive portfolio of NIH-sponsored research, and continues to direct large federally-funded programs.  

Stan Miele, BA

PRESIDENT

A recognized global executive with success in sales, marketing and P&L leadership in the pharmaceutical/medical device and biotech industries. Mr. Miele was formally the Chief Commercial Officer at bioLytical Laboratories and Sucampo Pharmaceuticals Inc.  He was also President of Sucampo Pharma Americas for 6 years.   He was instrumental on some key licensing agreements for Sucampo, inclusive of the agreement with Abbott Japan, and also Takeda Pharmaceuticals (now Shire).  He is actively part of the team ensuring proper execution of clinical development, manufacturing, licensing, capital funding, alliances, and ensuring Aqualung meets all critical milestones.  He will be helping the company move toward accelerating the pipeline/platform technology and moving eNamptor™ toward commercialization.